Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Heart Failure Phase 4 ClinicalTrials
Heart Failure Phase 3 ClinicalTrials
Heart Failure Phase 4 ClinicalTrials
Hypertension Phase 3 ClinicalTrials
Essential Hypertension; Hypertension Phase 3 ClinicalTrials
Mitral Valve Insufficiency; Ventricular Dysfunction; Ventricular Dysfunction, Left Phase 4 ClinicalTrials
Erectile Dysfunction; Heart Failure; Heart Failure, Systolic Phase 3 ClinicalTrials
Heart Failure; Hypertension Phase 2 ClinicalTrials
Essential Hypertension; Hypertension Phase 3 ClinicalTrials
Liver Diseases Phase 2 ClinicalTrials
Heart Failure Phase 4 ClinicalTrials
Essential Hypertension; Hypertension Phase 2 ClinicalTrials
Hypertension Phase 2 ClinicalTrials
Heart Failure Phase 4 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Heart Failure Phase 4 ClinicalTrials
Heart Failure Phase 4 ClinicalTrials
Heart Diseases; Ventricular Remodeling Phase 3 ClinicalTrials
Heart Failure Phase 3 ClinicalTrials
Essential Hypertension; Hypertension Phase 3 ClinicalTrials
Hypertension Phase 4 ClinicalTrials
Peripheral Arterial Disease; Peripheral Vascular Diseases Phase 2 ClinicalTrials
Hypertension Phase 2 ClinicalTrials
Diabetes Mellitus; Diabetes Mellitus, Type 2 Phase 4 ClinicalTrials
Hypertension Phase 2 ClinicalTrials
Heart Failure Phase 2 ClinicalTrials
Hypertension; Renal Insufficiency Phase 3 ClinicalTrials
Essential Hypertension; Hypertension Phase 2 ClinicalTrials
Hypertension Phase 2 ClinicalTrials
Essential Hypertension; Hypertension Phase 3 ClinicalTrials
Heart Failure Phase 2 ClinicalTrials
Hypertension Phase 3 ClinicalTrials
Heart Failure Phase 2 ClinicalTrials
Heart Failure Phase 3 ClinicalTrials
Hypersensitivity; Hypertension Phase 2 ClinicalTrials
Hypertension Phase 3 ClinicalTrials
Heart Failure Phase 3 ClinicalTrials
Renal Insufficiency Phase 1 ClinicalTrials
Heart Failure Phase 3 ClinicalTrials
Essential Hypertension; Hypertension Phase 2 ClinicalTrials
Heart Failure Phase 2/Phase 3 ClinicalTrials
CONTENTS